Mylan entered the Australian market in 2007, following its acquisition of Alphapharm, a company supplying generic medicines in Australia since 1982.
From their manufacturing facility – one of Australia’s largest medicine manufacturing sites – right here in Queensland, they have built on this legacy in providing patients with greater access to affordable medicine in Australia and around the world.
By pioneering generic substitution of medicines in Australia, as well as offering a range of innovative brands, biosimilars and over the counter medicines, Mylan has transformed into one of Australia’s leading healthcare companies.
The company produces over 3 billion doses of oral solid dose medicine for Australian and export markets, with their Queensland-made medicine found in more than 40 countries around the world.
Last updated: 12 Sep 2020